about
Lung cancer ablation: technologies and techniquesPercutaneous radiofrequency ablation of painful osseous metastases: a multicenter American College of Radiology Imaging Network trialPercutaneous Image-guided Thermal Ablation and Radiation Therapy: Outcomes of Combined Treatment for 41 Patients with Inoperable Stage I/II Non–Small-Cell Lung CancerPercutaneous image-guided cryoablation of painful metastases involving bone: multicenter trial.Image-guided tumor ablation: proposal for standardization of terms and reporting criteria.Image-guided tumor ablation: standardization of terminology and reporting criteriaAdrenal neoplasms: CT-guided radiofrequency ablation--preliminary results.Research reporting standards for image-guided ablation of bone and soft tissue tumors.Radiofrequency ablation of medically inoperable stage IA non-small cell lung cancer: are early posttreatment PET findings predictive of treatment outcome?Percutaneous ablation of adrenal tumors.Radiofrequency ablation of bony metastatic disease.Irreversible electroporation in a Swine lung model.Irreversible electroporation of the pancreas in swine: a pilot studyThermal ablation of tumours: biological mechanisms and advances in therapy.Irreversible electroporation of the liver and liver hilum in swine.Current status of thermal ablation treatments for lung malignancies.High-throughput fractionation of human plasma for fast enrichment of low- and high-abundance proteinsCurrent role of image-guided ablative therapies in lung cancer.Thermal ablation of colorectal liver metastases: a position paper by an international panel of ablation experts, The Interventional Oncology Sans Frontières meeting 2013Microwave ablation: principles and applications.Hepatocellular carcinoma: microwave ablation with multiple straight and loop antenna clusters--pilot comparison with pathologic findings.Percutaneous minimally invasive therapies in the treatment of bone tumors: thermal ablation.Solitary painful osseous metastases: correlation of imaging features with pain palliation after radiofrequency ablation--a multicenter american college of radiology imaging network study.Microwave ablation of lung malignancies: effectiveness, CT findings, and safety in 50 patients.Microwave ablation in the treatment of primary lung tumors.Intra-operative microwave ablation of liver malignancies with tumour permittivity feedback control: a prospective ablate and resect study.Radiofrequency and microwave tumor ablation in patients with implanted cardiac devices: is it safe?Radiofrequency ablation of colorectal hepatic metastases.Radiofrequency ablation: a safe and effective treatment in nonoperative patients with early-stage lung cancer.Pulmonary thermal ablation in patients with prior pneumonectomy.Computed tomographic diagnosis of pneumatosis intestinalis: clinical measures predictive of the need for surgical intervention.Solid renal masses: effectiveness and safety of image-guided percutaneous radiofrequency ablation.Intraoperative microwave ablation of pulmonary malignancies with tumor permittivity feedback control: ablation and resection study in 10 consecutive patients.Placement of marker coils at biopsy: usefulness in the localization of poorly visualized renal neoplasms for subsequent CT-guided radiofrequency ablation.Rib fractures after percutaneous radiofrequency and microwave ablation of lung tumors: incidence and relevance.Microwave ablation devices for interventional oncology.Treatment of medically inoperable non-small-cell lung cancer with stereotactic body radiation therapy versus image-guided tumor ablation: can interventional radiology compete?How to set up a successful tumor ablation practice.Percutaneous ablation for small renal masses-imaging follow-upMicrowave ablation of focal hepatic malignancies regardless of size: A 9-year retrospective study of 64 patients.
P50
Q26827382-79987065-BCA0-4920-B59A-ABD68AA6BEBCQ28269037-7B632C63-32F7-468F-BB8B-66452812D517Q29029203-99497896-F581-4509-B9E7-4734AF28E958Q29041684-345429E4-7140-4C7D-984F-FEAE6A61E6D7Q30974061-00E3F233-C50C-4985-85AA-0113AD2D91ACQ31161842-51791097-113E-4B34-A932-7C45C9CEAC82Q33359800-F04FBC8F-AA2F-46B1-9851-98ED312F8F20Q33513350-2998D028-A4D7-4226-B6DA-A0E4CA953954Q33776980-FB024CD1-DC02-4ACD-A396-F7F17577C62EQ33914797-D60913ED-8133-41A7-8DFC-2F21B85CE186Q33981160-11F18B58-1336-4D28-8D1F-C943BEC93EE5Q34156938-C786B5F4-B1D2-44B7-9A41-27D59828A90AQ34184547-DB37EDE5-78CB-4B3A-994F-9AAAAD40E47BQ34406134-C9C21C95-FBDE-4162-865E-4B6A8667EB5FQ34625532-CA4CE56D-5132-43D1-AF1F-E4711E127876Q35882898-15D2BC06-4C56-482D-99D0-C2A496CBACD6Q36162778-4FF466FF-92F6-4856-AC58-6C84B94BD5F6Q36235561-58175D72-F253-4C9E-A366-189B3AB7081EQ36258276-40693E13-E6FE-4662-81A7-73BE75F00BF5Q36287678-A15F37E7-1820-4678-A2E9-B7D6EBB17776Q36403097-645848AA-BDEB-4D60-8E69-7004798367EFQ36442020-40577537-4C96-41E2-83CA-E8FFD1CBB7DAQ37113260-7D217156-4782-411D-A740-60578891A8C0Q37121411-9213B2FE-A26D-45E7-8974-4D3F0B4EB6C1Q37225522-290A1EE0-371E-4EE9-9D25-B9B490D4D376Q37350326-1C5479E0-008C-43D0-9C4E-FB73FC4E1C9BQ37740550-B40D9E0C-196D-4743-A9FF-FD22530A2EFCQ37821852-A95E604D-8FDF-4865-8A35-AF58685C0FA6Q37832095-49612968-0AE4-4EC5-BCE4-D948EAC71331Q37867882-035408A2-C094-4237-A35E-953EC6C841ACQ37876043-E61B4C37-6F71-42EB-BEBA-0CF0EA28427DQ37942022-07F3B592-3F40-4A9E-B5F1-CC79C302FE13Q37959430-2611BD97-6D20-4D4A-99D1-8971702A6428Q37992027-2D7C836E-164B-4EA4-839E-1B7D0978BA7AQ38073732-914C50D9-F4D3-49E4-8C31-7BA617767E8CQ38088272-6E20BF07-5872-4EB0-9A5D-1C6FEC92EADCQ38116685-00E476BD-68AB-4E56-B06C-3C233E14125CQ38163113-D4A8E968-CFAE-41D0-AFA4-F96774836A92Q38193424-4D3E4C3B-4FA5-4FB6-BB51-4768D14D9609Q38394470-9660677F-5A57-43A3-8F93-879CB0E84DE1
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Damian E Dupuy
@nl
Damian E Dupuy
@sl
Damian E. Dupuy
@en
Damian E. Dupuy
@es
type
label
Damian E Dupuy
@nl
Damian E Dupuy
@sl
Damian E. Dupuy
@en
Damian E. Dupuy
@es
prefLabel
Damian E Dupuy
@nl
Damian E Dupuy
@sl
Damian E. Dupuy
@en
Damian E. Dupuy
@es
P108
P106
P1153
7005979100
P21
P31
P496
0000-0003-0524-5982